Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 10 for ALS - Amyotrophic lateral sclerosis

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study to Evaluate the Safety, Pharmacokinetics and Biodistribution of an Imaging Agent, 18F-OP-801 (18F Hydroxyl Dendrimer) in Patients With Amyotrophic Lateral Sclerosis (ALS) and Healthy Volunteers (HV)

    Jacksonville, FL

  2. TJ-68 Clinical Trial in Patients with Amyotrophic Lateral Sclerosis (ALS) and Muscle Cramps

    Jacksonville, FL, Scottsdale/Phoenix, AZ

  3. A Study to Evaluate MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients with Amyotrophic Lateral Sclerosis (ALS)

    Jacksonville, FL

  4. HEALEY ALS Platform Trial

    Jacksonville, FL, Rochester, MN, Scottsdale/Phoenix, AZ

  5. A Study of Ibubilast in Amyotrophic Lateral Sclerosis (ALS)

    Jacksonville, FL

  6. RAPA-501 Therapy for ALS Expanded Access Protocol

    Scottsdale/Phoenix, AZ

  7. Intrathecally Administered Gene Therapy APB-102 in Rapidly Progressive ALS Patients with SOD1 Mutations

    Jacksonville, FL, Rochester, MN

  8. Immune Phenotyping in Amyotrophic Lateral Sclerosis

    Rochester, MN

  9. Target ALS Biomarker Study

    Jacksonville, FL

  10. Blood and Spinal Fluid Collection for Research Studies in Motor Neuron Disease and Motor Neuropathy

    Rochester, MN

.

Mayo Clinic Footer